Afelimomab

Afelimomab (MAK 195F) is an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment. Afelimomab can be used for the research of sepsis.

$ 2,215.60 2215.6 USD $ 2,215.60 VAT Excluded

2,215.60 € VAT Excluded

This combination does not exist.

Add to cart Buy now

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Customer Reviews